Olema Pharmaceuticals Inc (OLMA)
Who owns Olema Pharmaceuticals Inc (OLMA)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 73.5% of the shares are freely tradable; institutional investors hold 119.4%.
Ownership Structure
Largest Shareholders
Institutions
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| FMR Inc | 11.89 | 10,386,845 | +106.8 | 03/31/2026 |
| Paradigm Biocapital Advisors LP | 9.18 | 8,020,576 | +6.3 | 03/31/2026 |
| Bain Capital Life Sciences Investors, LLC | 8.56 | 7,473,238 | -12.2 | 03/31/2026 |
| HHG PLC | 8.14 | 7,108,488 | +5.9 | 03/31/2026 |
| BlackRock Inc | 6.47 | 5,652,135 | +1.6 | 03/31/2026 |
| Bvf Inc | 6.06 | 5,295,893 | +0.0 | 03/31/2026 |
| Siren, L.L.C. | 5.45 | 4,756,949 | +44.1 | 03/31/2026 |
| State Street Corp | 4.51 | 3,937,831 | +109.0 | 03/31/2026 |
| Cormorant Asset Management, LLC | 4.46 | 3,900,000 | +41.8 | 03/31/2026 |
| Logos Global Management LP | 3.67 | 3,208,875 | +0.0 | 03/31/2026 |
Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.
Insider Transactions
| Date | Person | Role | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 24. Jul 2026 | Harmon Cyrus | Director | Sell | 12,500 | 11.71 | 146,425 |
| 23. Jul 2026 | Harmon Cyrus | Director | Sell | 12,500 | 11.58 | 144,738 |
Reportable transactions by officers and major shareholders from SEC Form 4 filings. "Other" includes things like stock grants and option exercises without a buy/sell character.
View all insider transactions →Data as of: August 3, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.